AFP and hepatocellular carcinoma: The biomarkers protein induced by vitamin K absence/antagonist-II (PIVKA-II), also known as des-gamma carboxyprothrombin (DCP), and AFP-L3, a glycosylated form of AFP that is more specific to liver cancer, have been investigated as additional HCC biomarkers.